BioPharmX Corporation (NYSE: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced the pricing of an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE